68Ga-OncoACP3

Ga-68-OncoACP3 · Philogen S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-OncoACP3, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer [Phase 1]